Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Blood Cancer J
; 14(1): 32, 2024 02 20.
Article
em En
| MEDLINE
| ID: mdl-38378617
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Leucemia Mieloide Aguda
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article